Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.

MLA

Carlos, Fernando, et al. “Economic Evaluation of Duloxetine as a First-Line Treatment for Painful Diabetic Peripheral Neuropathy in Mexico.” Journal of Medical Economics, vol. 15, no. 2, 2012, pp. 233–44. EBSCOhost, https://doi.org/10.3111/13696998.2011.640730.

APA

Carlos, F., Ramírez-Gámez, J., Dueñas, H., Galindo-Suárez, R. M., & Ramos, E. (2012). Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico. Journal of Medical Economics, 15(2), 233–244. https://doi.org/10.3111/13696998.2011.640730

Chicago

Carlos, Fernando, Jocelyn Ramírez-Gámez, Héctor Dueñas, Rosa María Galindo-Suárez, and Elisa Ramos. 2012. “Economic Evaluation of Duloxetine as a First-Line Treatment for Painful Diabetic Peripheral Neuropathy in Mexico.” Journal of Medical Economics 15 (2): 233–44. doi:10.3111/13696998.2011.640730.